Healthy Aging Health Center
Solitude Speeds Effects of Aging
June 22, 2009 -- An active social life may help elderly people fight the effects of aging.
A new study shows that older adults who seldom participate in social activities experience a faster rate of motor function decline than those with an active social life. Researchers found that each point decrease in a person's social activity score was associated with a 33% faster rate of motor function decline.
Motor function decline such as decreased muscle strength, coordination, and dexterity is commonly associated with aging and related to dementia, potentially disabling falls, and even death.
Although motor function decline is a growing public health concern, researchers say little is known about factors that contribute to the problem or what interventions may help slow its progression.
Solitude Speeds Decline
The study, published in the Archives of Internal Medicine, analyzed the relationship between participation in social activities and motor function decline in 906 older adults followed for about five years. None of the participants had a history of Parkinson's disease, stroke, or dementia on entry into the study.
Researchers evaluated the participants' motor function by testing grip and pinch strength, balance on one leg, placing pegs on a board quickly, and walking in line heel to toe. The participants also filled out a survey to measure their social activity and used a five-point scale to assess their level of social activity. Examples of social activity included going to restaurants, playing bingo, volunteering, visiting friends or family, and attending religious services.
The results showed that elderly people with less social activity had a more rapid rate of motor function decline.
In addition, a one-point decrease in social activity was equivalent to being about five years older at the start of the study. Researchers say that translates to a 40% higher risk of death and 65% higher risk of disability.
Researcher Aron S. Buchman, MD and colleagues at Rush University Medical Center in Chicago say the findings raise the possibility that social activity may slow motor function decline and the negative health effects associated with it in elderly people. But they say more study is needed to confirm this as a cause-and-effect relationship.
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRIPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.


